Related references
Note: Only part of the references are listed.Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome
Aritz Lopategi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function
Amanda J. Kennedy et al.
PHARMACOLOGICAL REVIEWS (2018)
Role of smooth muscle cells in coronary artery bypass grafting failure
Kerry Wadey et al.
CARDIOVASCULAR RESEARCH (2018)
ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages
Andres Laguna-Fernandez et al.
CIRCULATION (2018)
Abnormal cannabidiol confers cardioprotection in diabetic rats independent of glycemic control
Asmaa I. Matouk et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Resolvin E1 attenuates injury-induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration
Guizhu Liu et al.
FASEB JOURNAL (2018)
Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure
Ganesh V. Halade et al.
FASEB JOURNAL (2018)
Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats
Gang Zuo et al.
MOLECULAR BRAIN (2018)
Resolution of Inflammation Through the Lipoxin and ALX/FPR2 Receptor Pathway Protects Against Abdominal Aortic Aneurysms
Marcelo H. Petri et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2018)
Early treatment with Resolvin E1 facilitates myocardial recovery from ischaemia in mice
Guizhu Liu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Novel Resolvin D2 Receptor Axis in Infectious Inflammation
Nan Chiang et al.
JOURNAL OF IMMUNOLOGY (2017)
The endogenous lipid N-arachidonoyl glycine is hypotensive and nitric oxide-cGMP-dependent vasorelaxant
Yousuf M. Al Suleimani et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats
Asmaa I. Matouk et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2017)
Association of a variant in the gene encoding for ERV1/ChemR23 with reduced inflammation in visceral adipose tissue from morbidly obese individuals
Cristina Lopez-Vicario et al.
SCIENTIFIC REPORTS (2017)
Resolvin D1 via prevention of ROS-mediated SHP2 inactivation protects endothelial adherens junction integrity and barrier function
Rima Chattopadhyay et al.
REDOX BIOLOGY (2017)
Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (CAMP/PKA) pathway
Giorgio Mottola et al.
PLOS ONE (2017)
ERV1 Overexpression in Myeloid Cells Protects against High Fat Diet Induced Obesity and Glucose Intolerance
Corneliu Sima et al.
SCIENTIFIC REPORTS (2017)
Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E-/- mice
Marcelo H. Petri et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
The inflammatory cytokine interferon-gamma inhibits sortilin-1 expression in hepatocytes via the JAK/STAT pathway
John Pirault et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Boosting Inflammation Resolution in Atherosclerosis The Next Frontier for Therapy
Gabrielle Fredman et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin
Kanita Salic et al.
ATHEROSCLEROSIS (2016)
Formyl-Peptide Receptor 2/3/Lipoxin A4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation Impact for Therapy in Cardiovascular Disease
Shantel A. Vital et al.
CIRCULATION (2016)
Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation
Michael J. Zhang et al.
CIRCULATION (2016)
Resolvin D3 Is Dysregulated in Arthritis and Reduces Arthritic Inflammation
Hildur H. Arnardottir et al.
JOURNAL OF IMMUNOLOGY (2016)
Resolvin D1 Polarizes Primary Human Macrophages toward a Proresolution Phenotype through GPR32
Mattia Schmid et al.
JOURNAL OF IMMUNOLOGY (2016)
Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment
Regina M. Krohn et al.
JOURNAL OF INFLAMMATION-LONDON (2016)
Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses
Valerio Chiurchiu et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent
Sarah K. Orr et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis
Hatice Hasturk et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
The Adipokine Chemerin Induces Apoptosis in Cardiomyocytes
Diego Rodriguez-Penas et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke
Helen K. Smith et al.
FASEB JOURNAL (2015)
Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice
Daisuke Akagi et al.
FASEB JOURNAL (2015)
Identification of resolvin D2 receptor mediating resolution of infections and organ protection
Nan Chiang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Regulation of atherosclerotic plaque inflammation
M. Back et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function
Vasundhara Kain et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Anti-inflammatory therapies for atherosclerosis
Magnus Back et al.
NATURE REVIEWS CARDIOLOGY (2015)
Differential regulation of monocytic expression of leukotriene and lipoxin receptors
Marcelo Heron Petri et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2015)
Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice
Gabrielle Fredman et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation
Mauro Perretti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability
Marcelo H. Petri et al.
CARDIOVASCULAR RESEARCH (2015)
Annexin A1 Counteracts Chemokine-Induced Arterial Myeloid Cell Recruitment
Maik Drechsler et al.
CIRCULATION RESEARCH (2015)
Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction
Vasundhara Kain et al.
BASIC RESEARCH IN CARDIOLOGY (2014)
Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7
Magnus Back et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Resolution of inflammation: targeting GPCRs that interact with lipids and peptides
Jenna L. Cash et al.
DRUG DISCOVERY TODAY (2014)
GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte compartment
Xiaoming Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Pro-resolving lipid mediators are leads for resolution physiology
Charles N. Serhan
NATURE (2014)
Chemerin Induces Insulin Resistance in Rat Cardiomyocytes in Part through the ERK1/2 Signaling Pathway
Ruining Zhang et al.
PHARMACOLOGY (2014)
Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway
Gabrielle Fredman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation
Vincenzo Brancaleone et al.
BLOOD (2013)
Integrative pathway dissection of molecular mechanisms of moxLDL-induced vascular smooth muscle phenotype transformation
George S. Karagiannis et al.
BMC CARDIOVASCULAR DISORDERS (2013)
Biomechanical factors in the biology of aortic wall and aortic valve diseases
Magnus Back et al.
CARDIOVASCULAR RESEARCH (2013)
Resolvin D3 and Aspirin-Triggered Resolvin D3 Are Potent Immunoresolvents
Jesmond Dalli et al.
CHEMISTRY & BIOLOGY (2013)
D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury
Takuya Miyahara et al.
FASEB JOURNAL (2013)
Resolvin E1 and Chemokine-like Receptor 1 Mediate Bone Preservation
Li Gao et al.
JOURNAL OF IMMUNOLOGY (2013)
Proresolving and Tissue-Protective Actions of Annexin A1-Based Cleavage-Resistant Peptides Are Mediated by Formyl Peptide Receptor 2/Lipoxin A4 Receptor
Jesmond Dalli et al.
JOURNAL OF IMMUNOLOGY (2013)
Lipoxin A4 Regulates Natural Killer Cell and Type 2 Innate Lymphoid Cell Activation in Asthma
Cindy Barnig et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands
Anthony P. Davenport et al.
PHARMACOLOGICAL REVIEWS (2013)
Resolvin D1 Receptor Stereoselectivity and Regulation of Inflammation and Proresolving MicroRNAs
Sriram Krishnamoorthy et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
N-arachidonoyl glycine induces macrophage apoptosis via GPR18
Rina Takenouchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Δ9-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells
Douglas McHugh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Lack of Neutrophil-Derived CRAMP Reduces Atherosclerosis in Mice
Yvonne Doering et al.
CIRCULATION RESEARCH (2012)
Chemical Mediators of Inflammation and Resolution in Post-Operative Abdominal Aortic Aneurysm Patients
Padmini S. Pillai et al.
INFLAMMATION (2012)
Infection regulates pro-resolving mediators that lower antibiotic requirements
Nan Chiang et al.
NATURE (2012)
The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques
Janine M. van Gils et al.
NATURE IMMUNOLOGY (2012)
Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation
Driss El Kebir et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Pro-resolving lipid mediators (SPMs) and their actions in regulating miRNA in novel resolution circuits in inflammation
Antonio Recchiuti et al.
FRONTIERS IN IMMUNOLOGY (2012)
Liberation of desmosine and isodesmosine as amino acids from insoluble elastin by elastolytic proteases
Hideyuki Umeda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans
Jean-Baptiste Michel et al.
CARDIOVASCULAR RESEARCH (2011)
Blockade of cysteinyl leukotriene-1 receptors suppresses airway remodelling in mice overexpressing GATA-3
T. Kiwamoto et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2011)
MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits
Antonio Recchiuti et al.
FASEB JOURNAL (2011)
Aspirin-Triggered Lipoxin and Resolvin E1 Modulate Vascular Smooth Muscle Phenotype and Correlate with Peripheral Atherosclerosis
Karen J. Ho et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Resolvin E1 protects the rat heart against reperfusion injury
K. T. Keyes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor
Douglas McHugh et al.
BMC NEUROSCIENCE (2010)
FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis
Paola Maderna et al.
FASEB JOURNAL (2010)
Resolvin E1 Receptor Activation Signals Phosphorylation and Phagocytosis
Taisuke Ohira et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Resolvin D1 binds human phagocytes with evidence for proresolving receptors
Sriram Krishnamoorthy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mediators of neutrophil recruitment in human abdominal aortic aneurysms
Xavier Houard et al.
CARDIOVASCULAR RESEARCH (2009)
Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophil-derived leukotriene B4 as a major chemotactic factor released from the intraluminal thrombus
Xavier Houard et al.
FASEB JOURNAL (2009)
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
R. D. Ye et al.
PHARMACOLOGICAL REVIEWS (2009)
Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation
Makoto Arita et al.
JOURNAL OF IMMUNOLOGY (2007)
Involvement of the antimicrobial peptide LL-37 in human atherosclerosis
Kristina Edfeldt et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
The lipoxin receptor ALX: Potent ligand-specific and stereoselective actions in vivo
Nan Chiang et al.
PHARMACOLOGICAL REVIEWS (2006)
Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1
M Arita et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Activation of lipoxin A4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation
N Chiang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
